Patent Armory v. TriWest Healthcare Alliance: Voluntary Dismissal After 36 Days
Patent Armory, Inc. sued TriWest Healthcare Alliance Corp. in the District of Delaware asserting two patents covering auction-based entity matching and intelligent telephony call routing. The plaintiff voluntarily dismissed the action without prejudice just 36 days after filing, before TriWest answered or moved for summary judgment.
Pre-answer dismissal in a dual-patent assertion against a healthcare contractor
On October 29, 2025, Patent Armory, Inc. filed a patent infringement action against TriWest Healthcare Alliance Corp. in the United States District Court for the District of Delaware, assigned to Judge Maryellen Noreika. The complaint asserted two patents: US9456086B1, covering a method and system for matching entities in an auction, and US7023979B1, covering a telephony control system with intelligent call routing. TriWest Healthcare Alliance is a managed care contractor serving U.S. military veterans and their families.
On December 4, 2025 — only 36 days after filing — Patent Armory voluntarily dismissed the action without prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). This procedural mechanism is available as of right when the defendant has not yet served an answer or a motion for summary judgment, which was the case here. A dismissal without prejudice does not constitute a judgment on the merits and, in principle, preserves the plaintiff’s ability to refile the same claims against the same defendant, subject to applicable statutes of limitations and any other procedural constraints.
The 36-day lifecycle is notably short even by the standards of pre-answer dismissals. The public record does not disclose whether the parties reached a private settlement, a licensing arrangement, or whether Patent Armory simply chose to withdraw. The speed of the dismissal — before TriWest had even responded — suggests the matter may have been resolved commercially or that plaintiff reassessed its litigation strategy early. Without further filings, the underlying terms remain entirely undisclosed.
Filing to Voluntary dismissal in 36 days
36 days — resolved before defendant filed any responsive pleading
Voluntarily dismissed: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, no court approval needed
Federal Rule of Civil Procedure 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without prejudice, without a court order, at any time before the defendant has served an answer or a motion for summary judgment. TriWest had not done either, so Patent Armory exercised this right unilaterally. No judicial merits review occurred, and the court issued no ruling on the validity or infringement of either asserted patent.
No merits adjudicationWithout prejudice — but the public record says nothing more
A ‘without prejudice’ dismissal means the action is terminated without a binding judgment, preserving the plaintiff’s theoretical right to refile. A ‘with prejudice’ dismissal would bar the same claims permanently. The filed notice specifies ‘without prejudice,’ but the public record is silent on whether any private agreement — such as a license or covenant not to sue — was reached alongside the dismissal. Practitioners should not assume either outcome from the docket alone.
Refiling risk remains openTriWest exits without admitting liability or incurring a judgment
TriWest Healthcare Alliance Corp. was dismissed before needing to file a responsive pleading, meaning no invalidity counterclaims, no fee-shifting motion, and no judicial record of its defences. While this avoids immediate litigation cost, the without-prejudice nature of the dismissal means TriWest cannot treat this as a permanent resolution unless a private covenant or licence was secured. The absence of an answer also means no affirmative defences are on the public record.
No admission of liabilityShort lifecycle suggests early resolution or strategic withdrawal
A 36-day case ending in voluntary dismissal — before any substantive exchange — is consistent with either a rapid licensing negotiation, a decision by plaintiff to reassess claim strength, or a confidential settlement. For companies in healthcare IT, call routing, and digital marketplace infrastructure, this pattern signals that Patent Armory’s assertion posture may include early-stage monetisation attempts. Competitors and vendors operating similar matching or telephony routing systems should consider the continued validity of these patents until they are formally adjudicated or expired.
Monetisation pattern possibleFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Patent Armory, Inc. | Company | Patent assertion entity — holder of US9456086B1 and US7023979B1Search in Eureka ↗ |
| Defendant | TriWest Healthcare Alliance Corp. | Company | TriWest Healthcare Alliance Corp. — managed care contractor for U.S. military veteransSearch in Eureka ↗ |
| Plaintiff counsel | Brian E. Lutness | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Silverman, McDonald & Friedman | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Defendant counsel | Benjamin J. Schladweiler | Attorney | Counsel for TriWest Healthcare Alliance Corp.Search in Eureka ↗ |
| Defendant law firm | Greenberg Traurig LLP | Law Firm | Representing TriWest Healthcare Alliance Corp.Search in Eureka ↗ |
| Presiding judge | Judge Maryellen Noreika | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i) and expressly confirms that TriWest had not yet answered the complaint or moved for summary judgment — the precise preconditions that make a unilateral without-prejudice dismissal available as of right. The phrasing creates no judicial record on infringement, validity, or claim construction. For Patent Armory, the without-prejudice designation preserves optionality; for TriWest, the absence of a with-prejudice dismissal or a recorded licence means the threat is formally unresolved.
US9456086B1 & US7023979B1 — Entity Matching and Telephony Call Routing
US9456086B1 (application no. US12/719827) covers a method and system for matching entities in an auction context — technology relevant to digital marketplaces, referral engines, and procurement platforms that use competitive bidding logic to pair supply and demand. US7023979B1 (application no. US10/385389) covers a telephony control system with intelligent call routing, a foundational technology for contact-centre platforms, IVR systems, and managed care referral call flows. Both patents are U.S. utility patents granted by the USPTO.
Asserting these two patents together against a healthcare managed-care contractor suggests that Patent Armory characterised TriWest’s operations as encompassing both digital matching workflows and intelligent telephony functions — both common in military healthcare referral and benefits administration platforms. The combination of a marketplace-logic patent and a call-routing patent creates a broad assertion surface for any organisation running digital intake and telephony-based patient or beneficiary routing. Neither patent has been adjudicated on its merits in this action, leaving enforceability intact.
Should you run an FTO against US9456086B1 and US7023979B1?
Any organisation operating auction-style matching algorithms, digital referral platforms, or intelligent telephony routing — particularly in the healthcare, insurance, or managed services sectors — should evaluate its exposure to these two patents. Patent Armory’s assertion against a healthcare contractor signals active enforcement intent. Given the without-prejudice dismissal, the patents remain live enforcement risks, and no prior art or invalidity findings from this case can be relied upon.
PatSnap Eureka’s FTO Search Agent can map the independent and dependent claims of US9456086B1 and US7023979B1 against your product architecture, flag potentially overlapping prior art, and identify design-around opportunities. Eureka’s portfolio monitoring tools can also alert your team if Patent Armory refiles against TriWest or initiates new proceedings against comparable defendants — giving your legal and product teams early-warning intelligence before any complaint lands.
Run a freedom-to-operate analysis on US9456086B1 to assess your product’s exposure
Run FTO in Eureka →Similar patent assertion cases in healthcare IT and telephony call routing
Cases below involve patent assertions in entity-matching, call routing, or healthcare IT platforms litigated in the District of Delaware and comparable federal venues.
What this case signals for the healthcare IT and telephony IP landscape
A pre-answer voluntary dismissal involving two separately asserted patents rarely marks the end of a patentee’s enforcement campaign.
Patent Armory’s two-patent assertion strategy spans distinct technology domains
Asserting both an auction-based entity-matching patent and a telephony call-routing patent against a single healthcare contractor suggests a broad reading of TriWest’s platform capabilities. Companies operating digital intake, referral, or call-centre functions in healthcare should audit their exposure to both US9456086B1 and US7023979B1 before any potential refiling.
Pre-answer dismissals in Delaware often precede refiling or parallel campaigns
Statistical patterns in the District of Delaware suggest that without-prejudice dismissals at this stage frequently accompany either a licensing payment or a decision to refile in a different venue or against a different defendant. Monitoring Patent Armory’s subsequent filing activity is advisable for any company with comparable technology deployments.
Patent v TriWest — key questions answered
The plaintiff dismissed the case under Rule 41(a)(1)(A)(i) before TriWest filed any answer or summary judgment motion. A without-prejudice dismissal means no judgment was entered on the merits, and Patent Armory retains the theoretical right to refile the same patent claims against TriWest or other defendants. No court ruling on infringement, validity, or damages was issued.
Patent Armory asserted US9456086B1, covering a method and system for matching entities in an auction, and US7023979B1, covering a telephony control system with intelligent call routing. Both are U.S. utility patents. Neither was adjudicated on its merits in this action, leaving both fully enforceable.
A without-prejudice dismissal under Rule 41(a)(1)(A)(i) does not bar refiling, subject to applicable statutes of limitations. However, a second dismissal of the same action against the same defendant would operate as an adjudication on the merits under the ‘two-dismissal rule’ of Rule 41(a)(1)(B). Whether any private agreement limits refiling is not disclosed in the public record.
The public record does not disclose the reason. A 36-day pre-answer dismissal is consistent with several scenarios: a rapid licensing or settlement agreement, a plaintiff decision to reassess claim scope or defendant selection, or a strategic withdrawal to refile elsewhere. No financial terms or agreements are recorded on the docket.
US7023979B1 covers intelligent call routing in telephony control systems — technology widely deployed in managed care referral call centres, benefits administration hotlines, and patient intake platforms. The patent’s claims are not inherently limited to healthcare, meaning any organisation routing calls programmatically could fall within its scope. Companies should conduct FTO analysis before relying on similar routing architectures.
PatSnap Eureka searches patents and litigation data to answer instantly.